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Scrotal leiomyosarcoma is a rare tumor arising from the dartos layer of the scrotum presenting as ﬁrm,
rubbery, non-tender, irregular mass. To date about 37 cases of leiomyosarcoma of scrotum have so far
been reported. Treatment involves wide surgical excision with tumor free margins. We report a case of
scrotal leiomyosarcoma in a 48-year-old man which was treated by a wide surgical excision and follow
up of 14 months showed no recurrence of tumor.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Leiomyosarcomas of the scrotum, not involving the testis,
epididymis or spermatic cord, belong to the group of subcutaneous
superﬁcial leiomyosarcomas. Over 95% of all paratesticular leio-
myosarcomas are located in the spermatic cord or epididymis, and
their location in the scrotal skin or subcutaneous position in the
scrotum is exceptionally rare. Johnson H Jr. in 19871 reported the
ﬁrst known case of leiomyosarcoma of the scrotum and to date
about 37 cases of leiomyosarcoma of scrotum have been reported in
literature.2 The prognosis in general after a wide surgical excision
has been reported to be good because lymphatic metastases is very
rare; however a local recurrence rate of 40% has been reported.3 We
report a case of leiomyosarcoma scrotum in a 48-year old patient
presenting as a painless mass lesion.
Case report
A 40-year-old man presented with a ﬁrm, non-tender lump of
4 cm size in the posterior surface of scrotum in the subcutaneous
location (Fig. 1). The lump was mobile but attached to the primary
scar on the scrotal skin and not adherent to the underlying struc-
tures. This lesion ﬁrst appeared 2-years previously and a partial
excision of lump was done elsewhere, the histopathology of the
same was reported to be inconclusive and it gradually increased in
size in the past 6 months. Both testes epididymis and the spermaticþ91 5842393720.
rthy).
Inc. This is an open access article ucords were clinically normal, and there was no inguinal lymph-
adenopathy. There was no history of previous local irradiation or
long-term anabolic steroid abuse in the patient.
Hematological examination and routine biochemical in-
vestigations were within normal range. Ultrasound (USG) of the
scrotum revealed a well-circumscribed hypoechoic lesion
4 cm  3 cm in the subcutaneous plane separate from underlying
testes and epididymis.
Wide excision of lump was done with 1 cm margin around. The
histology report showed spindle cells of tumor were arranged in
fascicles containing eosinophilic cytoplasm prominent nucleoli and
presence of atypical mitosis suggestive of well differentiated leio-
myosarcoma (Fig. 2). Tumor Margins and base were free from tu-
mor extention. Immunohistochemistry showed the presence of
vimentin, desmin conﬁrming the smooth muscle origin of tumor. A
regular follow up for a period of 14 months did not show evidence
of local recurrence or distant metastasis.Discussion
Soft tissue sarcomas account for 1% of all malignancies. Leio-
myosarcomas constitute 10e20% of soft tissue sarcomas. Subcu-
taneous leiomyosarcomas account for 1e2% of all superﬁcial soft
tissue malignancies.4 Some of the more frequent malignant sarco-
matous tumors in scroum are-
 Rhabdomyosarcoma (RMS)
 Leiomyosarcoma
 Liposarcomander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Clinical picture showing mass in the posterior surface of scrotum.
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 Malignant ﬁbrous histiocytoma (MFH)
 Desmoplastic round cellLeiomyosarcoma
Leiomyosarcomas are malignant mesenchymal neoplasms
arising from smooth muscle. Leiomyosarcoma of the scrotum is a
very rare tumor presenting between the fourth and 8 decades of life
as a painless, slow-growing skin lesion of size 2e9 cm. Their loca-
tion in the scrotal skin or subcutaneous position in the scrotum is
exceptionally rare to date about 37 cases of leiomyosarcoma of
scrotum have been reported in literature.2 The etiology of leio-
myosarcomas remains unclear, though some authors suggest local
irradiation during childhood as a potential cause.
The diagnosis of leiomyosarcoma is based upon histological
examination of biopsy specimens. On histology they show spindle
cells with cigar shaped nuclei arranged in interweaving fascicles.
On immunohistochemistry leiomyosarcomas are positive for actin,
desmin and CD 34.5 The mode of spread of leiomyosarcoma is
primarily hematogenous to lung, liver and bone. The prognosis of
leiomyosarcoma depends upon the size, depth and grade of the
tumor and presence of distant metastases at diagnosis.Figure 2. Histology showed spindle cells of tumor arranged in fascicles with eosino-
philic cytoplasm.Rhabdomyosarcoma
The paratesticular region is the commonest site for the devel-
opment of RMS accounting for 20%. Although most of these tumors
occur in children and adolescents and 80% of RMS occur before the
age of 21-years. Clinically RMS present as an intrascrotal mass,
usually large. Histologically commonest subtypes seen are embry-
onal, alveolar, pleomorphic and mixed. Embryonal RMS is the
commonest variety in the paratesticular region.6,7
Liposarcoma
Liposarcomas account for z 20% of sarcomas seen in the
scrotum. From clinicopathological and cytogenetic features, three
distinct categories of liposarcoma are recognized; well
differentiated/de-differentiated, myxoid/round cell and pleomor-
phic. Most paratesticular liposarcomas are well differentiated. They
typically present in older adults as a large fatty appearing mass.8, 9
Malignant ﬁbrous histiocytoma
MFH is thought to account for a signiﬁcant proportion of tumors
in the adult paratesticular region. There are four histological sub-
types, i.e. myxoid, storiform-pleomorphic, inﬂammatory and giant
cell Most of the paratesticular MFH are of the storiform-
pleomorphic type. These tumors have a high local recurrence
rate, reportedly up to 51% after apparently complete surgical
excision.10
Desmoplastic round cell tumor
Desmoplastic round cell tumors (DRCTs) are highly aggressive
sarcomas. They are rare in the paratesticular region and occur in the
young adult, with an age distribution of 17e43-years. Cytogeneti-
cally, DRCTs have a unique translocation, t(11; 22) (p13; p12), that
results in fusion of the ESW gene on chromosome 22 to the WT-1
gene on chromosome 11.11
Management of paratesticular sarcomas
Sarcomas, like most malignant tumors, are classiﬁed according
to their grade and stage. The TNM system grades tumors according
to their degree of differentiation into four grades (G1, well differ-
entiated; G2, moderately differentiated; G3, poorly differentiated;
and G4, undifferentiated).
Treatment of paratesticular sarcomas
The optimum local and systemic treatment for these tumors
remains controversial, but there is a general consensus that all
scrotal sarcomas in adults should be managed with complete sur-
gical resection with safe margin. However, an oncologically
accepted safe margin of >10 mm, which gives a 84% local
recurrence-free interval at 5-years for soft tissue sarcomas has been
reported by McKee et al.12
Soft tissue sarcomas in most sites of the body have a tendency
for local recurrence after inadequate resection, and dissemination
of the disease is common for high-grade tumors. The reported local
relapse rate in the scrotum is 25e44%.3
Radiation therapy is also of doubtful value in treatment of
leiomyosarcoma except for palliation. Adjuvant locoregional radi-
ation and/or surgery apparently reduces the risk of local
recurrence.13
The role of retroperitoneal lymph node dissection (RPLND) in
paratesticular sarcomas remains controversial is not advocated;
D. Bansal et al. / Urology Case Reports 7 (2016) 42e4444unless a high degree of suspicion of for lymph node metastasis is
present. RPLND has been recommended by some authors especially
for patients with RMS, high-grade MFH and ﬁbrosarcoma, as these
patients are at high risk of retroperitoneal lymph node failure.
RPLND is not recommended in leiomyosarcoma.14
The role of adjuvant chemotherapy in adult paratesticular sar-
comas is not fully established. In children with paratesticular RMS
adjuvant chemotherapy has had a dramatic effect on the overall
survival.15 Thus, use of adjuvant chemotherapy for adult high-grade
sarcoma is controversial. Chemotherapy with gemcitabine, pacli-
taxel, vincristine, doxorubicin, actinomycin-D has been used with
limited success.
Recurrence most commonly tends to be local but distant me-
tastases in the bones and lungs have been reported.1 Nonetheless,
long-term follow up of patients with cutaneous leiomyosarcoma is
mandatory to detect local recurrence and distant metastases that
can occur years after the initial excision.Conﬂict of interest
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